title: Heparin-induced thrombocytopenia and antithrombotic therapy.
authors.forename: D M
authors.initials: DM
authors.lastname: Boon
authors.forename: J J
authors.initials: JJ
authors.lastname: Michiels
authors.forename: J
authors.initials: J
authors.lastname: Stibbe
authors.forename: H H
authors.initials: HH
authors.lastname: van Vliet
authors.forename: M C
authors.initials: MC
authors.lastname: Kappers-Klunne
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006496:Heparinoids / Q000627:therapeutic use*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy*; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006493:Heparin; D006496:Heparinoids; D006497:Heparan Sulfate; D014859:Warfarin; C035838:danaparoid